All News

RheumNow Podcast square

RheumNow Podcast - ACR 2021 Rehash (the good stuff..)

d Jack Cush, MD

The ACR 2021 meeting has concluded. Dr. Jack Cush recounts a few more great abstracts from this past week’s virtual meeting.

Read Article
DPGN, lupus, nephritis, GN, glomerulonephritis, biopsy, kidney

Racial/ethnic disparity in U.S. lupus nephritis mortality

d Janet Pope, MD, MPH, FRCPC

At #ACR21, the plenary session included an analysis of deaths from SLE throughout the US comparing 1999 to 2019 (Abstract #0454).

Read Article
Sign

Emapalumab for the treatment of macrophage activation syndrome

d Md Yuzaiful Md Yusof, MRCP(UK), PhD

Macrophage activation syndrome (MAS) is a term commonly used by rheumatologists to describe a potentially life-threatening complication of systemic inflammatory disorders, most commonly occurring in people with systemic juvenile idiopathic arthritis (sJIA) and systemic lupus erythematosus (SLE).

Read Article
heel enthesitis spur calcaneal

Predicting RA, and Treatment of Subclinical Arthritis

d Meral K. El Ramahi, MD, FACP, FACR

Identifying patients that will develop RA in situations of seropositivity without overt clinical arthritis or identifying patients with undifferentiated oligo/polyarthritis that will develop RA remains a challenge in the field of rheumatology. 

Read Article
unhappy%20patient.jpg

Psoriatic Arthritis: "What Matters" to Patients, Physicians

d Swetha Ann Alexander, MD

A study presented today by Mease et al. addresses the vital gap between what patients and physicians consider disabling because of PsA, and emphasizes “what matters” in a daily clinical encounter while dealing with PsA.

Read Article
ICYMI:Identifying Gaps in axSpA: Lessons from European Map of Axial Spondyloarthritis (EMAS) Dr. Sheila Reyes(@RHEUMarampa) discusses the three interesting abstracts were presented by the group of Prof. Marco Garrido-Cumbrera on the EMAS at #ACR21. https://t.co/5kOv5BUU4P https://t.co/lKuXC0mLRt

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: Risankizumab for Active Psoriatic Arthritis with Dr. Robert Chao ( @doctorRBC ) #ACR21 https://t.co/jRLem8YWpv https://t.co/5EQB1Y38Xs

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: COVID in Rheumatologic Disease Patients: Drs. Sparks, Liew, Yazdany and Dao provide an update on data specific to COVID in rheumatologic disease patients. @jeffsparks @drdavidliew @KDAO2011 #ACR21 https://t.co/jDGCpyTaPa https://t.co/58aehXyNzY

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: Towards better assessment and management of multimorbidity by Dr. Mrinalini Dey ( @DrMiniDey ) #ACR21 https://t.co/5G7PkWYrOH https://t.co/olsfrCyJw5

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow Podcast - #ACR21 Rehash (the good stuff…) The ACR 2021 meeting has concluded. Dr. Jack Cush recounts a few more great abstracts from this past week’s virtual meeting. https://t.co/6tuiajP4O7 https://t.co/cZeeVmrHqR

Links:

Dr. John Cush RheumNow ( View Tweet)
Infections in ORAL Surveillance: Drs. Kevin Winthrop and Jonathan Kay https://t.co/GtMtUh33QE https://t.co/yjJngF25Y4

Links:

Dr. John Cush RheumNow ( View Tweet)
Does Obesity Play a Role in Biologic Response? Dr. Eric Dein ( @ejdein1) discusses abstract #0588 presented at the #ACR21 annual meeting. https://t.co/yJNOFv3KOC https://t.co/KvBrFlXLfW

Links:

Dr. John Cush RheumNow ( View Tweet)
Radiographic Progression in SpA: Dr. Antoni Chan ( @synovialjoints ) discusses abstract #0907 and #0897 presented at the #ACR21 annual meeting. https://t.co/9hStWrfPOW https://t.co/XkgDjXE7Aq

Links:

Dr. John Cush RheumNow ( View Tweet)
Can "Ultra-low" dose Rituximab work for RA? At day 3 of #ACR21, the REDO trial presented data in abs1443 in an oral presentation challenging how low we can go with rituximab for rheumatoid arthritis. Dr. Eric Dein ( @ejdein1) shares highlights. https://t.co/jaTjBPRKVe https://t.co/7Q9nxlUt7R

Links:

Dr. John Cush RheumNow ( View Tweet)
Psoriatic Arthritis: What's with Brepocitinib? Dr. Eric Ruderman ( @JointMD ) discusses abstract #0488 presented at the #ACR21 annual meeting. https://t.co/mq0IMwyMSk https://t.co/oJAJS0DpQz

Links:

Dr. John Cush RheumNow ( View Tweet)
Lupus Day 2 Highlights: Drs Dao , Mehta, Yusof, Pope, Reyes and Castillo review lupus-related information and data presented during day 2 of the #ACR21 annual meeting. https://t.co/QX6Ay77FKo @KDAO2011 @bella_mehta @Yuz6Yusof @Janetbirdope @RHEUMarampa @_Castillo_Pedro https://t.co/ldAHqXsi0G

Links:

Dr. John Cush RheumNow ( View Tweet)
RA: Cardiovascular Risk Stratification and Potential Predictors of Risk Dr. El Ramahi ( @MeralElRamahiMD ) shares important takeaways from abstracts presented at #ACR21. https://t.co/69E7aA0Wag https://t.co/6nR5TLeyga

Links:

Dr. John Cush RheumNow ( View Tweet)
Spondyloarthritis Roundtable Rehash of #ACR21 New therapies, delay in diagnosis, artificial intelligence in reading radiographs and MRIs, and more. Panelists includes Dr. Alexis Ogdie-Beatty, Dr. Jose Scher, Dr. Jack Cush and Dr. Christopher Ritchlin. https://t.co/K0pbddzLAF https://t.co/fS6wBNWOdJ

Links:

Dr. John Cush RheumNow ( View Tweet)
Day 4 Report from #ACR21 My favorite three presentations from day 4 at ACR 2021 included the following: -Breakthrough Infections in Rheumatic Disease Patients -Secukinumab in Giant Cell Arteritis -STOP-Gout – Febuxostat is Noninferior to Allopurinol https://t.co/zJRS5AHjc1 https://t.co/FuwCFCK14r

Links:

Dr. John Cush RheumNow ( View Tweet)
Cognitive Impairment in Patients with Rheumatoid Arthritis Dr. Akhil Sood ( @AkhilSoodMD) discusses abstracts presented at #ACR21. https://t.co/zz8auqZjIW https://t.co/RSHjyonBrj

Links:

Dr. John Cush RheumNow ( View Tweet)
×